Paper Title
AN UPDATE ON PATHOPHYSIOLOGY AND MANAGEMENT OF ALZHEIMER’S DISEASE
Article Identifiers
: Authors
Keywords
Keywords: Alzheimer's disease; memory; cholinergic hypothesis; cerebral spinal fluid; Tacrine; antioxidants
Abstract
ABSTRACT Alzheimer's disease (AD), the most common neurodegenerative condition, produces growing problems in memory, cognition, and behaviour and ultimately leads in death. In addition to neuronal and synaptic loss, intracellular neurofibrillary tangles and extracellular senile plaques also develop in the brain as a result of Alzheimer's disease. Alzheimer's disease, the most common form of dementia, is the only one of the top 10 causes of death in the US for which there is no effective treatment. Numerous studies show that factors such as age, some genetic components, diet, and nutrition all raise the risk of AD. Several hypotheses explain the pathophysiology of AD includingamyloid cascade hypothesis, Tau hypothesis, cholinergic hypothesis, mitochondrial cascade theory, metabolic hypothesis. Genetic factors play a role in the development ofAlzheimer's disease; characterised by insulin/IGF resistance and insufficiency in the brain.In mild Alzheimer's disease patient suffers memory loss that disrupts daily life, losing track of dates or knowing current location etc. while in severe cases patient in unable to communicate, have no awareness of recent experiences or surroundings, increased sleeping, loss of bowel and bladder control etc. Alzheimer's, physicians may use medical history, mental status tests, physical and neurological exams, diagnostic tests and brain imaging to diagnose the disease. Cerebral spinal fluid tests for low beta-amyloid 42 and increased tau is helpful to diagnose preclinical stage AD treatment aims to enhance the patient's functioning and quality of life. Tacrine, donepezil, galantamine, and rivastigmine are the four medications that have received FDA approval for the treatment of Alzheimer's disease. In this overview, we discuss the various theories regarding its onset, symptoms, and treatments, including cholinesterase inhibitors, beta-amyloid ligands, antioxidants, antipsychotics, novel drug delivery systems, and the effects of diet and exercise on AD.
Downloads
How To Cite (APA)
Dr. Charulata Tushar Nemade, Tejal Mahale, Vishakha Gangwal, Akshada Shinde, & Hitesh V. Shahare (July-2023). AN UPDATE ON PATHOPHYSIOLOGY AND MANAGEMENT OF ALZHEIMER’S DISEASE. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(7), d93-d106. https://ijnrd.org/papers/IJNRD2307312.pdf
Issue
Volume 8 Issue 7, July-2023
Pages : d93-d106
Other Publication Details
Paper Reg. ID: IJNRD_202048
Published Paper Id: IJNRD2307312
Downloads: 000121997
Research Area: Pharmacy
Author Type: Indian Author
Country: Nashik, Maharashtra, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2307312.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2307312
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: November 2025
Current Issue: Volume 10 | Issue 11 | November 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 30-Nov-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
